COMPOSITIONS, KITS AND METHODS FOR ADMINISTERING A TITRATION SCHEDULE COMPRISING BIFEPRUNOX COMPOUNDS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 5, 2008
app pub date -
Aug 29, 2007
filing date -
Aug 31, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present disclosure is directed to a composition regimen, a titration kit, and methods of administration to facilitate the initiation of the treatment of at least one central nervous system condition or disorder by administering a plurality of dosage units of at least one bifeprunox compound, such as 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl ]-2(3H)-benzoxazolone (INN bifeprunox), according to a titration schedule.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully